SABS – sab biotherapeutics, inc. (US:NASDAQ)

Sec Filings

Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Woodline Partners LP
Form 10-Q SAB Biotherapeutics, For: Sep 30
Form 424B3 SAB Biotherapeutics,
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com